@SamRuff_MD

Asst Prof @UVA. Surg Onc/HPB Fellowship @OSUCCC_James. Gen Surg Residency @Northwellhealth. I plan to see the world.

Joined April 2021
  • Tweets23
  • Following125
  • Followers199
Samantha Ruff retweeted
SSAT@SSATNews14 May 2025
Congratulations to Dr. Samantha M. Ruff, MD, from the University of Virginia, on being named the 2025–2027 Career Development Award Recipient! @SamRuff_MD @UVASurgery #SSAT #SSATAWARDS
5
1
24
1,853
Replying to @SamRuff_MD
@samruff_md recently performed @uvahealthnews's 1st Cytoreduction Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC), a combo used to treat patients with advanced abdominal cancer. Click here to learn more: bit.ly/4gIfdRw
2
2
1
11
2,020
The Role of Targeted Therapy in the Multi-Disciplinary Approach to Colorectal Liver Metastasis mdpi.com/2376222 #mdpicancers via @Cancers_MDPI @timpawlik

The Role of Targeted Therapy in the Multi-Disciplinary Approach to Colorectal Liver Metastasis

Colorectal cancer (CRC) is the second most common cause of cancer-related mortality in the United States. Among newly diagnosed patients with CRC, 20% will present with metastatic disease and another...

mdpi.com
1
9
1,067
Check out new review in @CurrentOncology on Current Landscape of Immune Checkpoint Inhibitor Therapy for #Hepatocellular Carcinoma by @SamRuff_MD & @OhioStateSurg #HPB TEAM! ▶️ mdpi.com/1718-7729/30/6/439 @AEjaz85 @mary_dillhoff @jcloydmd @OSUWexMed @OSUCCC_James @AHPBA @SocSurgOnc

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma

The liver maintains a balance between immune tolerance and activation in its role as a filtration system. Chronic inflammation disrupts this immune microenvironment, thereby allowing for the rise and...

mdpi.com
7
1
17
3,314
❗❗Hot off the press ✅Review: "Surgical management of intrahepatic cholangiocarcinoma" by Dr. Samantha M. Ruff and Dr. Timothy M. Pawlik #icca #surgery #lymphadenectomy #meded Feel free to read hrjournal.net/article/downlo… via @HepatomaRes
1
29
110
11,841
The future of fibroblast growth factor receptor inhibitors and mechanisms of resistance for cholangiocarcinoma tandfonline.com/doi/full/10.… @timpawlik

The future of fibroblast growth factor receptor inhibitors and mechanisms of resistance for...

Cholangiocarcinoma (CCA) is a rare cancer that arises from the biliary tract. Despite advances in multimodal treatment, patients with CCA have a poor prognosis. Molecular profiling of CCA has ident...

tandfonline.com
3
9
1,707
Developments in FGFR and IDH inhibitors for cholangiocarcinoma therapy tandfonline.com/doi/full/10.… @timpawlik @DrZacharyJBrown

Developments in FGFR and IDH inhibitors for cholangiocarcinoma therapy

Cholangiocarcinoma (CCA) is an uncommon malignancy originating from epithelial cells of the biliary tract. Regardless of the site of origin within the biliary tree, CCAs are generally aggressive wi...

tandfonline.com
2
5
887
A Review of Translational Research for Targeted Therapy for Metastatic Colorectal Cancer mdpi.com/2154386 #mdpicancers via @Cancers_MDPI @timpawlik

A Review of Translational Research for Targeted Therapy for Metastatic Colorectal Cancer

Colorectal cancer is the third most common cause of cancer-related death in the United States, with 20% of patients presenting with metastatic disease at the time of diagnosis. Metastatic colon...

mdpi.com
1
1
7
966
Check out this new paper by our @OhioStateSurg team Highlighting novel targets in immunotherapy for liver cancer tandfonline.com/doi/full/10.… @IHPBA @AHPBA @SocSurgOnc @SSATNews @OSUWexMed @OSUCCC_James @OhioStateMed @OhioStateNews #hepatocellular #liver #cancer

Highlighting novel targets in immunotherapy for liver cancer

Alterations to the hepatic immune microenvironment can play a key role in the development and progression of cancer. This is especially true in the liver due to its evolutionarily conserved immunot...

tandfonline.com
2
2
4
3,718
Check out this new paper by our @OhioStateSurg research group on Current Treatments for #Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to Progress. @AHPBA @IHPBA @SocSurgOnc @SSATNews @OSUCCC_James @OSUWexMed @DovePress dovepress.com/articles.php?a…

Current treatments for hepatocellular carcinoma | JHC | Dove Medical Press

Clinical and molecular treatment modalities related to the treatment of hepatocellular carcinoma

dovepress.com
6
16
Thank you! I am very excited about this opportunity! @OSUCCC_James #hpb #cgso #theohiostate
Valerie Grignol@vpgrignol16 Oct 2022
Congratulations to our first #CGSO #HPB combined fellow @SamRuff_MD @OSUCCC_James @OhioStateSurg!
1
1
10
Samantha Ruff retweeted
Neha Lad@nehalad7982 Apr 2022
Congrats @SamRuff_MD @DKDePeralta on ampullary NETs @IHPBA @NorthwellHealth
1
4
14
Dr. Samantha Ruff completed undergrad @JohnsHopkins, entered @ZuckerSoM & stayed @NorthwellHealth for #GenSurg. Dr. Ruff spent 2 research years @NIH & starts Surgical Oncology fellowship @OhioState this summer! Outside the OR, she’s traveled to 14 countries & hopes to see the 🌎
1
3
27
For this weeks #AHPBA #JuniorSurgeonsCommittee - thoughts on resection for multifocal HCC? Criteria? ⁦@timnewhook19⁩ ⁦@vreelant⁩ ⁦@OscarKSerrano⁩ ⁦@Nachomerlo⁩ ⁦@MiguelTobonL⁩ ⁦@ArvindSabesan⁩ ⁦@RSnyder_MD⁩ hpbonline.org/article/S1365-…
5
10
26
Honored and proud to have had any role in this amazing project! I cannot imagine having had a better lab experience than my two years at the NIH with @JMHernandez_MD @NCICCR_SurgOnc
This Post is from an account that no longer exists. Learn more
1
1
14
Very excited to be joining Ohio State for #surgonc fellowship!! @OSUSurgery @OSUCCC_James
13
3
123
Very proud that so many of our former #surgonc research fellows @theNCI matched into really terrific #CGSO fellowship programs today: MSKCC MD Anderson Ohio State Moffitt City of Hope Pittsburgh Louisville @SocSurgOnc @NCIResearchCtr
3
7
4
78
Congratulations Dr. Hernandez! You’re an incredible mentor and this is well deserved!
This Post is from an account that no longer exists. Learn more
10
Just certified my rank list for the #surgonc match! Life is happening!
24
In print now, results of our Phase II study using confocal endomicroscopy to detect early #gastriccancer for #CDH1. Great work by an amazing team @NIHClinicalCntr. @NCIResearchCtr @NCICCR_Foregut bit.ly/2SwLLrx
1
11
3
38
Load more